13D Filing: Lion Point and Ditech Holding Corp (DHCP)

Pursuant to the effectiveness of the Chapter 11 Plan, (x) each share of common stock of WAC was exchanged for the following new securities of the Issuer:
(i) 0.05689208 Shares, 0.09692659 Series A Warrants and (iii) 0.07690920 Series B Warrants and (y) every $1000 principal amount of Senior Notes was exchanged for 464.11293167 New Second Lien Notes and 0.18564517 shares of Mandatorily
Convertible Preferred Stock of the Issuer, and (z) every $1000 principal amount of Convertible Notes was exchanged for 8.76919841 Shares, 14.94011581 Series A Warrants and 11.85465711 Series B Warrants of the Issuer. The Mandatorily Convertible
Preferred Stock is convertible at an initial conversion ratio of 114.975 Shares for each share of issued and outstanding Mandatorily Convertible Preferred Stock; the Mandatorily Convertible Preferred Stock is mandatorily convertible at the earliest
of (a) February 9, 2023, (b) at any time following one year after the Effective Date, the time that the volume weighted average pricing of the Shares exceeds 150% of the conversion price per share for at least 45 trading days in a 60
consecutive trading day period, including each of the last 20 days in such 60 consecutive trading day period, and (c) a change of control transaction in which the consideration paid or payable per Share is greater than or equal to $8.6975. The
Series A Warrants are exercisable on a cash or cashless basis at an exercise price of $20.63 per Share and expire on February 9, 2028 at 5:00 p.m., New York City time. The Series B Warrants are exercisable on a cash or cashless basis at an
exercise price of $28.25 per Share and expire on February 9, 2028 at 5:00 p.m., New York City time.

Following the effectiveness of the Chapter 11
Plan, each Reporting Person owned (i) 185,906 Shares, (ii) 5,999 shares of Mandatorily Convertible Preferred Stock, (iii) 316,729 Shares underlying the Reporting Persons Series A Warrants and (iv) 251,317 Shares underlying the Reporting
Persons Series B Warrants.

On February 20, 2018, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons
agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer. The Joint Filing Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Other than as
described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.